Yadin Rozov, Director at ORAMED PHARMACEUTICALS INC. (ORMP), bought 120,000 shares at $2.05 ($244K) on 2023-03-14, disclosed to the SEC on 2023-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.96 | 20,000 | $39K | 16.1% |
| 2 | $2.05 | 50,000 | $102K | 42.0% |
| 3 | $2.05 | 50,000 | $103K | 42.0% |
| Total | $2.04 avg | 120,000 | $244K | 100% |
| Filing → |
| DAVE | SELL | 2025-06-05 | $1.1M | — | Filing → |
| CORZ | BUY | 2025-05-29 | $1.2M | — | Filing → |
| CORZ | SELL | 2024-11-22 | $1.9M | — | Filing → |